Meet the 50 most investible Canadian cleantech ventures transforming the future of climate solutions globally

CALGARY, Alberta, Nov. 09, 2023 (GLOBE NEWSWIRE) — Canada’s 50 most investible cleantech ventures have been announced by Foresight Canada, the country’s largest cleantech ecosystem accelerator. The Foresight 50 features inspiring cleantech ventures across a range of industries and sectors that provide solutions to some of society’s most pressing issues including green housing, emissions reduction, and food security. […]

Read More »

Recursion Announces Data Collaboration Deal with Tempus, Top 50 Supercomputer Ambition Powered by NVIDIA, and Updated Focus of Collaboration with Bayer to Precision Oncology

With additional patient-centric data, compute power, and an exciting new focus for its Bayer collaboration, the company is accelerating the shift of biotech to techbio SALT LAKE CITY, Nov. 09, 2023 (GLOBE NEWSWIRE) —  Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced two significant updates with […]

Read More »

Pacific Green Enters Agreement to Secure Strategic Site to Develop 0.5GW / 1.0GWh Battery Energy Park in South Australia

Dover, DE, Nov. 09, 2023 (GLOBE NEWSWIRE) — / Pacific Green Technologies, Inc. (“Pacific Green”), (OTCQB: PGTK) announces that Pacific Green Technologies (Australia) Pty Ltd., a wholly owned subsidiary of Pacific Green, has entered into an exclusivity agreement to secure a strategically located land site in Limestone Coast, South Australia to develop a 0.5 GW / […]

Read More »

SLT (CognivAiD™) Improves Memory and Cognition in Individuals With Mild Cognitive Impairment: Clinical Trial Results

Investigator-initiated clinical trial of SLT (CognivAiD™) for mild cognitive impairment, led by Western Sydney University’s NICM Health Research Institute. Trial results reported that CognivAiD™ significantly improved key cognitive domains of episodic memory and executive function, and was well-tolerated. SINGAPORE, Nov. 09, 2023 (GLOBE NEWSWIRE) — Moleac, a biopharmaceutical company pioneering innovative therapeutics in neurology, announced promising […]

Read More »